March 23, 2025 - 10:21

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) have taken a significant step by sending a letter to the U.S. Food and Drug Administration (FDA). This letter, supported by over 20 prominent organizations and providers from various sectors of healthcare, emphasizes the urgent need for the FDA to implement and enforce federal regulations concerning compounding practices.
The call to action comes in the wake of recent shortages of GLP-1 medications, which are crucial for the treatment of obesity and related conditions. These shortages have raised serious concerns about patient access to essential therapies. The coalition argues that without stricter oversight and regulation of compounded medications, patients may face continued disruptions in their treatment options.
Healthcare leaders are advocating for a timely response from the FDA to ensure that patients receive the medications they need without interruption, highlighting the importance of regulatory frameworks in safeguarding public health.
October 13, 2026 - 07:44
Tree Canopy Goals Could Prevent Thousands of Premature Deaths Across US CitiesA new study suggests that expanding urban tree coverage could have a significant impact on public health, potentially preventing tens of thousands of premature deaths each year. Researchers found...
October 12, 2026 - 22:28
Brandi Glanville Shares a Frightening Update on Her Health Battle: 'Something Is in My Face Eating It'Brandi Glanville is speaking out about the severity of her ongoing health crisis, and her latest update paints a troubling picture. During a recent episode of her Unfiltered podcast, the...
October 12, 2026 - 13:32
Growth for Montana Global Health is an easy pill to swallowThe process starts when a client approaches the company with a concept for a new product. From that first conversation, the business takes over the heavy lifting. Raw materials are sourced from...
October 11, 2026 - 23:21
Blood proteins may offer new clues to gut health in celiac diseaseCeliac disease is an autoimmune condition in which the immune system reacts adversely to gluten. Eating gluten causes inflammation in the gut, which can damage the intestine and impair its ability...